Baird lowered the firm’s price target on Novanta (NOVT) to $133 from $139 and keeps a Neutral rating on the shares. The firm updated its model as it believes the sales bottom looks in place and the outlook for 2026 looks potentially favorable.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOVT: